Different human disorders involve IL-33 as a potent trigger of inflammatory processes, such as Rheumatoid Arthritis, Systemic Sclerosis, Sjörgen Disease and Psoriasis (47–50). The gene discussed is IL33; the disease is systemic sclerosis.